P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases

Oral Oncology

Volumn 35, Issue 4, 1999, Pages 384-389

  Tjebbes, G W A ^a   Leppers vd Straat, F G J ^a   Tilanus, M G J ^a   Hordijk, G J ^a   Slootweg, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

DNA sequencing analysis; Head and neck squamous cell carcinoma; Lymph node metastases; P53; RNA sequencing analysis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DNA SEQUENCE; FEMALE; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, P53; GENETIC MARKERS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 0033168810     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00127-4     Document Type: Article

References (41)

1. Schwartz L.H., Ozsahin M., Zhang G.N., Touboul E., De Vataire F., Andolenko P., Lacau-Saint-Guily J., Laugier A., Schlienger M. Synchronous and metachronous head and neck carcinomas. Cancer. 74:1994;1933-1938.
2. Franco E.L., Kowalski L.P., Kanda J.L. Risk factors for second cancers of the upper respiratory and digestive systems: a case control study. Journal of Clinical Epidemiology. 44:1991;615-625.
3. Slaughter D.P., Southwick H.W., Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer. 6:1953;963-968.
4. Slootweg P.J., Hordijk G.J., Koole R. Autopsy findings in patients with head and neck squamous cell cancer and their therapeutic relevance. European Journal of Cancer. 32:1996;413-415.
5. Bedi G.C., Westra W.H., Gabrielson E., Koch W., Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Research. 56:1996;2484-2487.
6. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S., Hittelman W., Hong W.K. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Medicine. 2:1996;682-685.
7. Wu C.L., Sloan P., Read A.P., Harris R., Thakker N. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Research. 54:1994;6484-6488.
8. Nawroz H., Van der Riet P., Hruban R.H., Koch W., Ruppert J.M., Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Research. 54:1994;1152-1155.
9. Leong P.P., Rezai B., Koch W.M., Reed A., Eisele D., Lee D.J., Sidransky D., Jen J., Westra W.H. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Journal of the National Cancer Institute. 90:1998;972-977.
10. Califano J., Van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W., Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Research. 56:1996;2488-2492.
11. Hung J., Kishimoto Y., Sugio K., Virmani A., McIntire D.D., Minna J.D., Gazdar A.F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA. 273:1995;558-563.
12. Sun P.C., El-Mofty S.K., Haughey B.H., Scholnick S.B. Allelic loss in squamous cell carcinomas of the larynx: discordance between primary and metastatic tumors. Genes Chromosomes Cancer. 14:1995;145-148.
13. Hori H., Miyake S., Akiyama Y., Endo M., Yuasa Y. Clonal heterogeneity in human esophageal squamous cell carcinomas on DNA analysis. Japanese Journal of Cancer Research. 87:1996;923-929.
14. Ogden G.R., Hall P.A. Field change, clonality, and early epithelial cancer: possible lessons from p53. Journal of Pathology. 181:1997;127-129.
15. Murry C.E., Gipaya C.T., Bartesek T., Benditt E.P., Schwartz S.M. Monoclonality of smooth muscle cells in human atherosclerosis. American Journal of Pathology. 151:1997;697-705.
16. Worsham M.J., Wolman S.R., Carey T.E., Zarbo R.J., Benninger M.S., Van Dyke D.L. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Human Pathology. 26:1995;251-261.
17. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research. 54:1994;4855-4878.
18. Chung K.Y., Mukhopadhyay T., Kim J., Casson A., Ro J.Y., Goepfert H., Hong W.K., Roth J.A. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Research. 53:1993;1676-1683.
19. Burns J.E., McFarlane R., Clark L.J., Mitchell R., Robertson G., Soutar D., Parkinson E.K. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue. European Journal of Cancer B Oral Oncology. 30B:1994;335-337.
20. Koch W.M., Boyle J.O., Mao L., Hakim J., Hruban R.H., Sidransky D. p53 gene mutations as markers of tumor spread in synchronous oral cancers. Archives of Otolaryngology - Head and Neck Surgery. 120:1994;943-947.
21. Zariwala M., Schmid S., Pfaltz M., Ohgaki H., Kleihues P., Schäfer R. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node metastases. International Journal of Cancer. 56:1994;807-811.
22. Ahomadegbe J.C., Barrois M., Fogel S., Le Bihan M.L., Douc-Rasy S., Duvillard P., Armand J.P., Riou G. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases: absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene. 10:1995;1217-1227.
23. Peller S., Halevy A., Slutzki S., Kopilova Y., Rotter V. p53 mutations in matched primary and metastatic human tumors. Molecular Carcinogenesis. 13:1995;166-172.
24. Kandioler D., Dekan G., End A., Pasching E., Buchmayer H., Gnant M., Langmann F., Mannhalter C., Eckersberger F., Wolner E. Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors. Journal of Thoracic and Cardiovascular Surgery. 111:1996;827-831.
25. Ribeiro U., Safatle-Ribeiro A.V., Posner M.C., Rosendale B., Bakker A., Swalsky P.A., Kim R., Reynolds J.C., Finkelstein M.A. Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract. Surgery. 120:1996;45-53.
26. Taniguchi Y., Gemma A., Takeda Y., Takenaka K., Niitani H., Kudoh S., Shimada T. Stability of p53 tumor suppressor gene mutations during the process of metastasis and during chemotherapy. Lung Cancer. 14:1996;219-228.
27. Mayama T., Mori T., Abe K., Sasano H., Nishihira T., Satomi S., Horii A. Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus. European Journal of Surgical Oncology. 23:1997;298-303.
28. Zhang S.Y., Bauer B., Mitsunaga S., Goodrow T.L., Klein Szanto A.J. Lack of concordant p53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis. Molecular Carcinogenesis. 12:1995;77-81.
29. Kropveld A., Van Mansveld A.D., Nabben N., Hordijk G.J., Slootweg P.J. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. European Journal of Cancer B Oral Oncology. 32B:1996;388-393.
30. Sozzi G., Miozzo M., Pastorino U., Pilotti S., Donghi R., Giarola M., De Gregorio L., Manenti G., Radice P., Minoletti F., Della Porta G., Pierotti M.A. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Research. 55:1995;135-140.
31. Yang H.K., Linnoila R.I., Conrad N.K., Krasna M.J., Ainser S.C., Johnson B.E., Kelly M.J. TP53 and ras mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. International Journal of Cancer. 64:1995;229-233.
32. Kropveld A. p53 in Diagnosis and Treatment of Head and Neck Cancer. PhD Thesis, Utrecht, The Netherlands: University of Utrecht, 1998.
33. Carey T.E. Field cancerization: are multiple primary cancers monoclonal or polyclonal? Annals of Medicine. 28:1996;183-188.
34. Spiessl B. UICC, International Union Against Cancer. TNM-Atlas: Illustrated Guide to the TNM/pTNM-Classification of Malignant Tumors, 3rd Edition. New York: Springer, 1990.
35. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 16:1988;1215.
36. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Science, USA. 74:1977;5463-5467.
37. Rozemuller E.H., Eliaou J.F., Baxter-Lowe L.A., Charron D., Kronick M., Tilanus M.G. An evaluation of a multicenter study on HLA-DPB1 typing using solid-phase Taq-cycle sequencing chemistry. Tissue Antigens. 46:1995;96-103.
38. Grossman P.D., Bloch W., Brinson E., Chang C.C., Eggerding F.A., Fung S., Iovannisci D.A., Woo S., Winn-Deen E.S. High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Research. 22:1994;4527-4534.
39. Munirajan A.K., Tutsumi-Isshii Y., Mohanprasad B.K., Hirano Y., Munakata N., Shanmugam G., Tsuchida N. p53 gene mutations in oral carcinomas from India. International Journal of Cancer. 66:1996;297-300.
40. Kusama K., Okutsu S., Takeda A., Himiya T., Kojima A., Kidokoro Y., Chu L., Iwanari S., Kudo I., Moro I. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. Journal of Pathology. 178:1996;415-421.
41. Koch W.M., Patel H., Brennan J., Boyle J.O., Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Archives of Otolaryngology - Head and Neck Surgery. 121:1995;262-265.